Each capsule contains Piracetam 400 mg.

Neurocetam Capsules contain Piracetam, a well-established nootropic agent that supports cognitive function by improving neuronal membrane fluidity and enhancing communication between brain cells. It helps protect neuronal integrity, promotes cognitive performance, and supports neurological function. The formulation is used as an adjunctive therapy in the symptomatic treatment of cortical myoclonus and contributes to the restoration of cognitive abilities by improving neuronal metabolism and membrane stability.

Neurocetam Capsules are indicated for the symptomatic treatment of cortical myoclonus in adult patients, irrespective of its underlying cause. It is recommended for use in combination with other anti-myoclonic therapies to improve symptom control and neurological function.

Piracetam acts by binding to the polar heads of phospholipids in neuronal cell membranes, restoring membrane fluidity and stability through the formation of mobile drug-phospholipid complexes. This action helps maintain the structural integrity and function of membrane proteins, thereby enhancing neuronal communication and synaptic transmission. Piracetam also exhibits neuroprotective properties that help preserve and restore cognitive functions while improving overall brain performance.

The recommended dosage is two capsules daily, one in the morning and one in the evening. Neurocetam Capsules may be taken with or without food, or as directed by the physician.

Neurocetam Capsules are contraindicated in patients with known hypersensitivity to Piracetam, other pyrrolidone derivatives, or any component of the formulation. It should not be used in patients with cerebral hemorrhage, Huntington's chorea, or end-stage renal disease.